98%
921
2 minutes
20
Purpose: This quantitative study aimed to determine whether the quality of discharge teaching, anxiety, depression, and various demographic and disease-related factors predict discharge readiness among cervical cancer surgical patients in Western Region of China.
Methods: From November 2023 to May 2024, a convenience sampling method was employed to administer a questionnaire to cervical cancer surgery patients at a tertiary Grade A specialized hospital in Xinjiang. The survey included a patient general information questionnaire, the Quality of Discharge Teaching Scale (QDTS), the Generalized Anxiety Disorder 7-item Scale (GAD-7), a questionnaire assessing the readiness for discharge of gynecological malignant tumor surgery patients under the enhanced recovery after surgery (ERAS) model, and the Patient Health Questionnaire-9 (PHQ-9). Multivariate linear regression analysis was used to identify factors influencing discharge readiness.
Results: A total of 180 cervical cancer surgery patients participated, yielding an average score of 190.46±25.36 on the gynecological malignant tumor discharge readiness questionnaire under the ERAS model. Multiple linear regression analysis indicated that education level, chronic diseases, medication use, quality of discharge teaching, and depressive mood were significant predictors of discharge readiness of cervical cancer surgery patients.
Conclusion: The overall discharge readiness of cervical cancer surgery patients was found to be at a moderate. Nurses should prioritize patients with lower education levels, chronic conditions, depression, and those requiring medication post-discharge. Personalized health guidance and targeted interventions should be developed to enhance the quality of discharge teaching, thereby improving patients' readiness for discharge.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11892361 | PMC |
http://dx.doi.org/10.2147/PPA.S495260 | DOI Listing |
J Clin Virol
September 2025
International HPV Reference Center, Center for Cervical Cancer Elimination, F56, Karolinska Institutet, Stockholm 14186, Sweden. Electronic address:
Background: Human papillomavirus (HPV) testing is the primary method for cervical cancer screening, but reliable detection depends on adequate sample cellularity. Cycle threshold (Ct) values for the assay's internal control (IC), such as β-globin, are commonly used as proxies for adequacy, yet standardized Ct cut-offs are lacking. We aimed to contribute evidence-based thresholds for sample adequacy using real-world data.
View Article and Find Full Text PDFKaohsiung J Med Sci
September 2025
Department of Gynecology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Ferroptosis resistance is a key player in cervical cancer (CC) development. Hypoxia is a negative factor affecting CC treatment by inducing ferroptosis resistance. Our study aimed to investigate the detailed mechanisms of hypoxia-induced ferroptosis resistance in CC cells.
View Article and Find Full Text PDFHealth Expect
October 2025
Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Introduction: Despite high coverage of routine childhood vaccines, uptake of the human papillomavirus (HPV) vaccine in the Pacific Island nation of Tonga has been slow. Culturally appropriate communication resources on the importance, safety, and effectiveness of the HPV vaccine are critical to support acceptance and uptake. To develop these resources, it is important to understand what people want to know.
View Article and Find Full Text PDFJ Relig Health
September 2025
Department of Midwifery, Faculty of Health Sciences, Agri Ibrahim Cecen University, Agri, Turkey.
This study aims to examine the effect of education interventions given to women with religious orientation on cervical cancer and Pap smear test health beliefs.The study used a quasi-experimental research design with the pre-test-post-test control group. It was conducted in Qur'an courses in a province in eastern Turkey between January and October 2023.
View Article and Find Full Text PDFInt J Radiat Oncol Biol Phys
September 2025
Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Electronic address:
Purpose: Recent immunotherapy trials in locally advanced cervical cancer report high PD-L1 positivity rates whereas academic multicentric initiatives report a lower PD-L1 positivity. These observations necessitate cross-clone comparison to understand the observed differences.
Methods: Two different clones used in previous multicentric international studies SP142 (BIOEMBRACE) and 22C3 (KEYNOTE-A18) were used to test PD-L1 positivity in a pilot cohort of FIGO 2018 stage III cervical cancer patients recruited in a phase III trial.